Emphysema Treatment Global Market Report 2024

Description

“Emphysema Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on emphysema treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for emphysema treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The emphysema treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Treatment: Smoking Cessation; Bronchodilators; Steroids; Leukotriene Modifiers; Supplemental Oxygen; Antibiotics; Gene Therapy; Surgery Transplant; Other Treatments
2) By Distribution Channel: Online Providers; Drug Stores and Retail Pharmacies; Hospital Pharmacies
3) By End-User: Clinics; Surgical Centre; Other End-Users
Companies Mentioned: AstraZeneca PLC; Teva Pharmaceutical Industries Ltd.; Novartis AG; GlaxoSmithKline PLC; Hikma Pharmaceuticals PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Emphysema treatment refers to medication for chronic obstructive pulmonary disease (COPD), a condition that leads to damage in the air sacs of the lungs, resulting in difficulty breathing. Treatments for emphysema aim to manage symptoms and slow the progression of the disease.

The primary treatments for emphysema include smoking cessation, bronchodilators, steroids, leukotriene modifiers, supplemental oxygen, antibiotics, gene therapy, surgery transplant, and others. Smoking cessation involves the cessation of smoking to reduce the risk of cancer and other significant health issues. This process helps minimize cravings and withdrawal symptoms while preventing nicotine binding. These treatments are available through various distribution channels, including online providers, drug stores, retail pharmacies, and hospital pharmacies. They are utilized by various end-users such as clinics, surgical centers, and others.

The emphysema treatment market research report is one of a series of new reports from The Business Research Company that provides emphysema treatment market statistics, including emphysema treatment industry global market size, regional shares, competitors with an emphysema treatment market share, detailed emphysema treatment market segments, market trends and opportunities, and any further data you may need to thrive in the emphysema treatment industry. This emphysema treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The emphysema treatment market size has grown strongly in recent years. It will grow from $4.96 billion in 2023 to $5.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The expansion observed in the historical period can be ascribed to the impact of the smoking epidemic, advancements in medications, the implementation of pulmonary rehabilitation programs, enhanced diagnostic tools, and increased awareness and education.

The emphysema treatment market size is expected to see strong growth in the next few years. It will grow to $6.85 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated growth in the forecast period can be linked to trends in the aging population, the adoption of customized treatment approaches, broader access to therapies, an emphasis on symptom management, and the implementation of collaborative healthcare models. Major trends expected in the forecast period involve the exploration of gene therapies, initiatives for patient education and empowerment, the integration of artificial intelligence (AI), improved accessibility to treatment, and the development of long-acting medications.

The anticipated increase in the prevalence of chronic obstructive pulmonary disease (COPD) cases is poised to drive the growth of the emphysema treatment market. COPD comprises a group of disorders, including emphysema and chronic bronchitis, leading to airflow obstruction and breathing difficulties. Emphysema treatments play a crucial role in mitigating the progression of COPD, focusing on symptom management, restoration of lung function, and delaying disease advancement. A study released by the Forum of International Respiratory Societies in September 2021 revealed that approximately 200 million people were diagnosed with COPD in 2021, with an annual mortality rate of around 3.2 million, ranking it as the third-leading cause of global mortality. Hence, the increasing prevalence of COPD cases is a driving force behind the emphysema treatment market.

The surge in air pollution is expected to contribute to the growth of the emphysema treatment market. Air pollution, characterized by the presence of harmful substances in the air, poses adverse effects on the environment and human health. Elevated levels of particulate matter and harmful gases in air pollution can exacerbate respiratory conditions, including COPD such as emphysema. The heightened exposure to air pollutants is likely to lead to an increase in respiratory diseases, fostering the demand for emphysema treatments. For example, in September 2021, IQAir, a Switzerland-based air quality technology company, reported a 25% rise in PM2.5 concentrations in Malaysia compared to the previous year. The recorded annual average for 2021, at 19.4 μg/m3, marked a significant increase of 3.8 μg/m3 from the levels observed in 2020. Consequently, the upsurge in air pollution is propelling the growth of the emphysema market.

Prominent companies in the emphysema market are striving to gain a competitive advantage by developing minimally invasive procedures tailored for emphysema patients. Minimally invasive procedures involve medical interventions or surgical techniques that aim to cause minimal disruption to the body's normal structures. For example, in January 2022, Adena Health System, a healthcare company based in the United States, introduced Zephyr Valve surgery as a minimally invasive alternative to traditional lung volume reduction surgery for individuals experiencing lung hyperinflation, a common issue in emphysema and COPD. This innovative procedure involves the placement of small, one-way Zephyr Valves in the lungs' airways through a bronchoscope. These valves facilitate the release of trapped air, preventing further accumulation and enabling healthier lung areas to expand, thereby improving breathing.

Leading companies in the emphysema market are also focusing on the development of innovative products, such as inhalation aerosols, to establish a competitive edge. Inhalation aerosols are pharmaceutical formulations dispensed as a fine mist or spray of liquid medication suspended in a propellant or propellant mixture. For instance, in July 2023, Viatris Inc., a U.S.-based pharmaceutical company, in collaboration with Kindeva Drug Delivery L.P., a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol. This marks the first FDA-approved generic version of AstraZeneca's Symbicort, catering to patients managing asthma, chronic obstructive pulmonary disease (COPD), and emphysema. Breyna, available in various dosage strengths, signifies a crucial advancement in providing accessible and cost-effective treatment options for individuals facing respiratory challenges.

In March 2023, UC Davis Health, an academic health institution based in the United States, entered into a collaboration with Propeller Health to offer individualized treatment for chronic obstructive pulmonary disease (COPD) and asthma through remote patient monitoring technology. This partnership allows UC Davis Health to provide eligible patients with Propeller Health's remote patient monitoring (RPM) service, delivering personalized therapy for high-risk COPD and asthma patients using sensors, a smartphone application, and a website. Propeller Health, a U.S.-based mobile platform company, provides sensors, mobile apps, analytics, and services to assist in respiratory health management.

Major companies operating in the emphysema treatment market report are AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Bioxyne Limited, Intrexon Corporation, iCure Pharmaceuticals Inc., Kamada Ltd., Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., British Technology Group International , Astellas Pharma Inc., Respinova Ltd., Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

North America was the largest region in the emphysema treatment market in 2023. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the emphysema treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The emphysema treatment market includes revenues earned by entities by providing medical services such as bronchodilator medications, anti-inflammatory medication, oxygen therapy, lifestyle change consultation, and interventional therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11697

1. Executive Summary

2. Emphysema Treatment Market Characteristics

3. Emphysema Treatment Market Trends And Strategies

4. Emphysema Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Emphysema Treatment Market Size and Growth

5.1. Global Emphysema Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Emphysema Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Emphysema Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Emphysema Treatment Market Segmentation

6.1. Global Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Smoking Cessation
Bronchodilators
Steroids
Leukotriene Modifiers
Supplemental Oxygen
Antibiotics
Gene Therapy
Surgery Transplant
Other Treatments
6.2. Global Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Online Providers
Drug Stores and Retail Pharmacies
Hospital Pharmacies
6.3. Global Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Clinics
Surgical Centre
Other End-Users

7. Emphysema Treatment Market Regional And Country Analysis

7.1. Global Emphysema Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Emphysema Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Emphysema Treatment Market

8.1. Asia-Pacific Emphysema Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Emphysema Treatment Market

9.1. China Emphysema Treatment Market Overview
9.2. China Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Emphysema Treatment Market

10.1. India Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Emphysema Treatment Market

11.1. Japan Emphysema Treatment Market Overview
11.2. Japan Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Emphysema Treatment Market

12.1. Australia Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Emphysema Treatment Market

13.1. Indonesia Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Emphysema Treatment Market

14.1. South Korea Emphysema Treatment Market Overview
14.2. South Korea Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Emphysema Treatment Market

15.1. Western Europe Emphysema Treatment Market Overview
15.2. Western Europe Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Emphysema Treatment Market

16.1. UK Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Emphysema Treatment Market

17.1. Germany Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Emphysema Treatment Market

18.1. France Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Emphysema Treatment Market

19.1. Italy Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Emphysema Treatment Market

20.1. Spain Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Emphysema Treatment Market

21.1. Eastern Europe Emphysema Treatment Market Overview
21.2. Eastern Europe Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Emphysema Treatment Market

22.1. Russia Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Emphysema Treatment Market

23.1. North America Emphysema Treatment Market Overview
23.2. North America Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Emphysema Treatment Market

24.1. USA Emphysema Treatment Market Overview
24.2. USA Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Emphysema Treatment Market

25.1. Canada Emphysema Treatment Market Overview
25.2. Canada Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Emphysema Treatment Market

26.1. South America Emphysema Treatment Market Overview
26.2. South America Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Emphysema Treatment Market

27.1. Brazil Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Emphysema Treatment Market

28.1. Middle East Emphysema Treatment Market Overview
28.2. Middle East Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Emphysema Treatment Market

29.1. Africa Emphysema Treatment Market Overview
29.2. Africa Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Emphysema Treatment Market Competitive Landscape And Company Profiles

30.1. Emphysema Treatment Market Competitive Landscape
30.2. Emphysema Treatment Market Company Profiles
- 30.2.1. AstraZeneca PLC
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Teva Pharmaceutical Industries Ltd.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Novartis AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. GlaxoSmithKline PLC
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Hikma Pharmaceuticals PLC
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Emphysema Treatment Market Competitive Benchmarking

32. Global Emphysema Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Emphysema Treatment Market

34. Emphysema Treatment Market Future Outlook and Potential Analysis

34.1 Emphysema Treatment Market In 2028 - Countries Offering Most New Opportunities
34.2 Emphysema Treatment Market In 2028 - Segments Offering Most New Opportunities
34.3 Emphysema Treatment Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer